Riemann, A.; Blaschke, M.; Jauho-Ghadimi, A.; Siggelkow, H.; Gollisch, K.S.C.
Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome. J. Clin. Med. 2022, 11, 4294.
https://doi.org/10.3390/jcm11154294
AMA Style
Riemann A, Blaschke M, Jauho-Ghadimi A, Siggelkow H, Gollisch KSC.
Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome. Journal of Clinical Medicine. 2022; 11(15):4294.
https://doi.org/10.3390/jcm11154294
Chicago/Turabian Style
Riemann, Annika, Martina Blaschke, Annukka Jauho-Ghadimi, Heide Siggelkow, and Katja Susanne Claudia Gollisch.
2022. "Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome" Journal of Clinical Medicine 11, no. 15: 4294.
https://doi.org/10.3390/jcm11154294
APA Style
Riemann, A., Blaschke, M., Jauho-Ghadimi, A., Siggelkow, H., & Gollisch, K. S. C.
(2022). Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome. Journal of Clinical Medicine, 11(15), 4294.
https://doi.org/10.3390/jcm11154294